1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Enteric Disease Testing and Treatment: Technologies and Global Markets

REPORT HIGHLIGHTS

The global market for diagnostics and preventive vaccines for enteric diseases reached $6.5 billion in 2013. This market should grow to $10 billion in 2014 and about $21.9 billion in 2018, a compound annual growth rate (CAGR) of 27.3%.

This report provides:

An overview of the global market for enteric disease testing and treatment.
Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2018.
Information on recent developments in diagnostic technology for specific pathogens or classes of pathogens.
A look at how poor drainage and sanitation along with overcrowding and low hygiene awareness account for the majority of enteric infection incidences globally.
Insight into recent advances like improved stool polymerase chain reaction assays which are impacting the industry.
Comprehensive profiles of major players in the field.

SCOPE OF THE STUDY

The scope of this study are the clinical testing and preventative vaccine markets for enteric diseases. The report also includes the clinical segment, currently approved diagnostic tests and their markets, current testing technologies, new technologies, enteric diseases, causative agents and global incidence, market projections and market share along with the latest trends and new developments in this area. This report does not include the treatment market or the research market including reagents, instruments or any accessories used for diagnostic testing sample preparation or analysis. Other enteric pathogens or intestinal cancers are outside the scope of this report.

Table Of Contents

Enteric Disease Testing and Treatment: Technologies and Global Markets
Chapter- 1: INTRODUCTION - Complimentary 4 $0

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF THE STUDY

METHODOLOGY
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: SUMMARY 3 $250

Table Summary : GLOBAL MARKET FOR DIAGNOSTICS AND PREVENTIVE VACCINES FOR ENTERIC DISEASES, THROUGH 2018
Figure Summary : GLOBAL MARKET FOR DIAGNOSTICS AND PREVENTIVE VACCINES FOR ENTERIC DISEASES, 2013-2018

Chapter- 3: OVERVIEW 40 $1900

ENTERIC DISEASES
ENTERIC PATHOGENS
HISTORICAL FACTS
CAUSES
PREVENTION AND CONTROL
DIARRHEA AND PATHOGENS
CONCLUSION

Chapter- 4: ENTERIC DISEASES: BIOLOGY 23 $1093

THE DIGESTIVE SYSTEM
MECHANISMS OF DIARRHEA
VARIOUS PATHOGENS
TREATMENT
TESTS
ENTERIC VACCINES

Chapter- 5: DIAGNOSIS 20 $950

NOVEL DIAGNOSTICS AND IMPACT ASSESSMENT
MAJOR INFECTIOUS DISEASE TESTS
CONCLUSION

Chapter- 6: TREATMENT 14 $665

ACUTE ENTERIC INFECTIONS
NEW DEVELOPMENTS
Table 37 : UNICEF/WHO: 7-POINT PLAN FOR DIARRHEAL DISEASE CONTROL

Chapter- 7: INCIDENCE 32 $1520

2012 FOODNET DATA
RECENT EFFORTS AND NEXT STEPS
WHAT IS FOODCORE?
DIARRHEA
TYPHOID
SHIGELLA
CAMPYLOBACTER
CHOLERA
NOROVIRUS
ROTAVIRUS
ENTEROTOXIGENIC E. COLI
AMEBIASIS
GIARDIA
CRYPTOSPORIDIUM
SUMMARY

Chapter- 8: ENTERIC DISEASE DIAGNOSTIC TESTING MARKET 36 $1710

ENTERIC DISEASE TESTING METHODS
GLOBAL ENTERIC DISEASE DIGNOSTICS
GLOBAL MARKET FOR ENTERIC DIAGNOSTIC TESTS
CONCLUSIONS AND CDC RECOMMENDATIONS

Chapter- 9: PREVENTION AND TREATMENT MARKET 26 $1235

TREATMENT MARKET FOR ENTERIC DISEASES
CURRENT SPREAD OF ENTERIC DISEASES
VACCINES: CURRENT MARKET DYNAMICS
CONCLUSIONS

Chapter- 10: COMPANY PROFILES 11 $523

ABBOTT LABORATORIES
ACTOGENIX NV
AFFYMETRIX
ASTELLAS PHARMA INC.
BAYER
BECKMAN COULTER INC.
BECTON DICKINSON AND COMPANY
BHARAT BIOTECH
BIOMERIEUX
BIO-RAD LABORATORIES
BRISTOL-MYERS SQUIBB CO.
CEPHEID
CRUCELL
DAIICHI SANKYO INC.
ELI LILLY and CO.
GLAXOSMITHKLINE
JOHNSON and JOHNSON
IDL BIOTECH
MERCK and CO.
NOVARTIS CORP.
PFIZER
QUEST DIAGNOSTICS
R-BIOPHARM AG
RESZON DIAGNOSTICS INTERNATIONAL
ROCHE
SANOFI
SPAN DIAGNOSTICS
TAKEDA PHARMACEUTICAL CO.
IMPORTANT NON-PROFIT SOURCES

Chapter- 11: REFERENCES 1 $48

List of Tables

Summary Table : GLOBAL MARKET FOR DIAGNOSTICS AND PREVENTIVE VACCINES FOR ENTERIC DISEASES, THROUGH 2018
Table 1 : COMMON CAUSAL AGENTS OF ENTERIC DISEASES
Table 2 : GLOBAL EXISTENCE OF DIARRHEA
Table 3 : PREVALENT ENTERIC DISEASE AND AGENTS
Table 4 : MODERN/RECENT OUTBREAKS
Table 5 : VIRUSES THAT CAUSE DIARRHEA
Table 6 : BACTERIA THAT CAUSE DIARRHEA
Table 7 : PARASITES THAT CAUSE DIARRHEA
Table 8 : KEY MEASURES TO REDUCE THE NUMBER OF CASES OF DIARRHEA
Table 9 : WATERBORNE CAUSES OF DIARRHEA
Table 10 : KEY POINTS
Table 11 : FOODNET CURRENT FINDINGS
Table 12 : PREVENTION TECHNIQUES FOR CAMPYLOBACTER INFECTIONS
Table 13 : CAUSATIVE PATHOGENS OF CHOLERA
Table 14 : CLINICAL FEATURES OF CHOLERA
Table 15 : TREATMENT: ANTIBIOTIC THERAPY
Table 16 : STRAINS OF PATHOGENIC E. COLI
Table 17 : PREVENTION TECHNIQUES FOR STEC INFECTIONS
Table 18 : TYPHOID SYMPTOMS
Table 19 : TWO LICENSED TYPHOID VACCINES
Table 20 : OTHER ILLNESSES DUE TO E. HISTOLYTICA INFECTION
Table 21 : THE DIGESTIVE PROCESS
Table 22 : KEY FACTORS IN DIGESTION
Table 23 : PROBLEMS WITH THE SMALL INTESTINE
Table 24 : INTESTINAL PROBLEMS: COMMON CAUSES
Table 25 : TYPES OF INFECTIONS AND AGENTS
Table 26 : TYPES OF DIARRHEA
Table 27 : GENES INVOLVED IN ENTERIC DISEASES
Table 28 : EVENTS THAT OCCUR UPON EXPOSURE TO SHIGELLA TOXIN
Table 29 : KEY FACTS OF DIARRHEA
Table 30 : EXAMS AND TESTS FOR TYPHOID
Table 31 : SHIGA TOXIN ANTIGEN TESTING IN CLINICAL MICROBIOLOGY LABORATORIES
Table 32 : DIAGNOSIS PROCESS
Table 33 : ENTEROPATHOGENS: CURRENT DIAGNOSTIC METHODS AND MOLECULAR TARGETS
Table 34 : OUTLINE FOR THE DIAGNOSIS OF TYPHOID FEVER
Table 35 : BASIC BLOOD TESTS: AMEBIASIS
Table 36 : EMERGING DIAGNOSTIC TECHNOLOGIES FOR ENTERIC DISEASES
Table 37 : UNICEF/WHO: 7-POINT PLAN FOR DIARRHEAL DISEASE CONTROL
Table 38 : TREATMENT AND CARE FOR DIARRHEA
Table 39 : TREATMENT FOR MILD DIARRHEA
Table 40 : TREATMENT FOR MODERATE DIARRHEA
Table 41 : TREATMENT FOR MEDICALLY IMPORTANT DIARRHEA
Table 42 : TREATMENT FOR SEVERE DIARRHEA
Table 43 : ANTIBIOTICS ASSOCIATED WITH COLITIS (AAC) TREATMENT
Table 44 : ANTIBIOTICS ASSOCIATED WITH COLITIS (AAC) TREATMENT
Table 45 : UNLICENSED VACCINES
Table 46 : ROTAVIRUS VACCINE
Table 47 : PROPORTIONAL DISTRIBUTION OF DIARRHEA CASES AMONG CHILDREN UNDER FIVE YEARS OF AGE BY REGION, 2004
Table 48 : GLOBAL BURDEN OF ENTERIC DISEASES, 2013
Table 49 : KEY FACTS OF GLOBAL BURDEN OF DIARRHEAL DISEASES
Table 50 : RISKS AND ETIOLOGIES OF GLOBAL BURDEN OF DIARRHEAL DISEASES
Table 51 : GLOBAL BURDEN OF TYPHOID EACH YEAR
Table 52 : GLOBAL BURDEN OF SHIGELLA EACH YEAR
Table 53 : GLOBAL BURDEN OF CAMPYLOBACTER EACH YEAR
Table 54 : CLINICAL PRESENTATION RATES OF PATHOGENIC VIBRIO INFECTIONS
Table 55 : GLOBAL BURDEN OF CHOLERA EACH YEAR
Table 56 : GLOBAL BURDEN OF NOROVIRUS EACH YEAR
Table 57 : GLOBAL BURDEN OF ETEC EACH YEAR
Table 58 : GLOBAL BURDEN OF AMEBIASIS EACH YEAR
Table 59 : GLOBAL BURDEN OF CRYPTOSPORIDIUM EACH YEAR
Table 60 : MEANS FOR THE SPREAD OF CRYPTOSPORIDIUM PARASITES
Table 61 : KEY FACTS OF GASTROINTESTINAL INFECTIONS IN U.S.
Table 62 : INDIVIDUAL PATHOGENS: NUMBER OF INFECTIONS AND U.S. INCIDENCE
Table 63 : ENTERIC DISEASE TESTING METHODS
Table 64 : ENTERIC DISEASE DIAGNOSTICS BY TYPES OF DISEASES
Table 65 : ENTERIC TESTING COSTS
Table 66 : GLOBAL MARKET FOR DIAGNOSTIC TESTS FOR ENTERIC DISEASES, THROUGH 2018
Table 67 : U.S. MARKET FOR DIAGNOSTIC TESTS FOR ENTERIC DISEASES, THROUGH 2018
Table 68 : TYPHOID TESTS
Table 69 : TYPHOID TESTS DETAILS
Table 70 : SEROLOGIC TESTS FOR TYPHOID
Table 71 : GLOBAL MARKET FOR TYPHOID DIAGNOSTIC TESTS, THROUGH 2018
Table 72 : TYPES OF CHOLERA TESTS ON THE MARKET
Table 73 : GLOBAL MARKET FOR CHOLERA DIAGNOSTIC TESTS, THROUGH 2018
Table 74 : C. DIFFICILE TESTS
Table 75 : CAMPYLOBACTER TESTS
Table 76 : GLOBAL MARKET FOR CAMPYLOBACTER DIAGNOSTIC TESTS, THROUGH 2018
Table 77 : U.S. MARKET FOR CAMPYLOBACTER DIAGNOSTIC TESTS, THROUGH 2018
Table 78 : GLOBAL MARKET FOR E. COLI DIAGNOSTIC TESTS, THROUGH 2018
Table 79 : U.S. MARKET FOR E. COLI DIAGNOSTIC TESTS, THROUGH 2018
Table 80 : GLOBAL MARKET FOR GIARDIA DIAGNOSTIC TESTS, THROUGH 2018
Table 81 : U.S. MARKET FOR GIARDIA DIAGNOSTIC TESTS, THROUGH 2018
Table 82 : GLOBAL MARKET FOR CRYPTOSPORIDIUM DIAGNOSTIC TESTS, THROUGH 2018
Table 83 : U.S. MARKET FOR CRYPTOSPORIDIUM DIAGNOSTIC TESTS, THROUGH 2018
Table 84 : FEATURES OF THE CRYPTOSPORIDIUM KIT FROM GENESIG
Table 85 : GLOBAL MARKET FOR AMEBIASIS DIAGNOSTIC TESTS, THROUGH 2018
Table 86 : U.S. MARKET FOR AMEBIASIS DIAGNOSTIC TESTS, THROUGH 2018
Table 87 : GLOBAL MARKET FOR SHIGELLA DIAGNOSTIC TESTS, THROUGH 2018
Table 88 : U.S. MARKET FOR SHIGELLA DIAGNOSTIC TESTS, THROUGH 2018
Table 89 : GLOBAL MARKET FOR NOROVIRUS DIAGNOSTIC TESTS, THROUGH 2018
Table 90 : U.S. MARKET FOR NOROVIRUS DIAGNOSTIC TESTS, THROUGH 2018
Table 91 : GLOBAL MARKET FOR ROTAVIRUS DIAGNOSTIC TESTS, THROUGH 2018
Table 92 : U.S. MARKET FOR ROTAVIRUS DIAGNOSTIC TESTS, THROUGH 2018
Table 93 : MAJOR VACCINES
Table 94 : GLOBAL PREVENTIVE VACCINE MARKET, ESTIMATES THROUGH 2018
Table 95 : GLOBAL ADULT VACCINE MARKET, ESTIMATES THROUGH 2018
Table 96 : TOTAL PEDIATRIC VACCINE MARKET, ESTIMATES, 2013 AND 2014
Table 97 : OTHER VACCINES MARKET, THROUGH 2018
Table 98 : MAJOR COMPETITORS IN THE GLOBAL VACCINES MARKET
Table 99 : GLOBAL MARKET FOR ENTERIC DISEASE VACCINES, THROUGH 2018
Table 100 : GLOBAL TYPHOID VACCINE MARKET, THROUGH 2018
Table 101 : TYPHOID VACCINES ON THE MARKET
Table 102 : ESTIMATED COSTS OF THE TYPHOID VACCINE IN THE U.S.
Table 103 : GLOBAL MARKET FOR CHOLERA VACCINE, THROUGH 2018
Table 104 : DEVELOPMENT OF BACTERIAL VACCINES, HISTORICAL PERSPECTIVE
Table 105 : CURRENTLY LICENSED VACCINES
Table 106 : ROTAVIRUS VACCINE KEY FACTS
Table 107 : VACCINATION SCHEDULE
Table 108 : COMPARISON OF ROTAVIRUS VACCINES
Table 109 : GLOBAL MARKET FOR ROTAVIRUS VACCINES, THROUGH 2018
Table 110 : CURRENTLY LICENSED ROTAVIRUS VACCINES
Table 111 : NEW ENTERIC DISEASE VACCINES IN DEVELOPMENT
Table 112 : VACCINES IN DEVELOPMENT
Table 113 : TRAVEL VACCINES MARKET, 2012 AND 2013

List of Figures

Summary Figure : GLOBAL MARKET FOR DIAGNOSTICS AND PREVENTIVE VACCINES FOR ENTERIC DISEASES, 2013-2018
Figure 1 : COMMON CAUSAL AGENTS OF ENTERIC DISEASES
Figure 2 : GLOBAL MARKET FOR DIAGNOSTIC TESTS FOR ENTERIC DISEASES, 2013-2018
Figure 3 : U.S. MARKET FOR DIAGNOSTIC TESTS FOR ENTERIC DISEASES, 2013-2018
Figure 4 : GLOBAL MARKET FOR TYPHOID DIAGNOSTIC TESTS, 2013-2018
Figure 5 : GLOBAL MARKET FOR CHOLERA DIAGNOSTIC TESTS, 2013-2018
Figure 6 : GLOBAL MARKET FOR CAMPYLOBACTER DIAGNOSTIC TESTS, 2013-2018
Figure 7 : U.S. MARKET FOR CAMPYLOBACTER DIAGNOSTIC TESTS, 2013-2018
Figure 8 : GLOBAL MARKET FOR E. COLI DIAGNOSTIC TESTS, 2013-2018
Figure 9 : U.S. MARKET FOR E. COLI DIAGNOSTIC TESTS, 2013-2018
Figure 10 : GLOBAL MARKET FOR GIARDIA DIAGNOSTIC TESTS, 2013-2018
Figure 11 : U.S. MARKET FOR GIARDIA DIAGNOSTIC TESTS, 2013-2018
Figure 12 : GLOBAL MARKET FOR CRYPTOSPORIDIUM DIAGNOSTIC TESTS, 2013-2018
Figure 13 : U.S. MARKET FOR CRYPTOSPORIDIUM DIAGNOSTIC TESTS, 2013-2018
Figure 14 : GLOBAL MARKET FOR AMEBIASIS DIAGNOSTIC TESTS, 2013-2018
Figure 15 : U.S. MARKET FOR AMEBIASIS DIAGNOSTIC TESTS, 2013-2018
Figure 16 : GLOBAL MARKET FOR SHIGELLA DIAGNOSTIC TESTS, 2013-2018
Figure 17 : U.S. MARKET FOR SHIGELLA DIAGNOSTIC TESTS, 2013-2018
Figure 18 : GLOBAL MARKET FOR NOROVIRUS DIAGNOSTIC TESTS, 2013-2018
Figure 19 : U.S. MARKET FOR NOROVIRUS DIAGNOSTIC TESTS, 2013-2018
Figure 20 : GLOBAL MARKET FOR ROTAVIRUS DIAGNOSTIC TESTS, 2013-2018
Figure 21 : U.S. MARKET FOR ROTAVIRUS DIAGNOSTIC TESTS, 2013-2018
Figure 22 : GLOBAL MARKET FOR ENTERIC DISEASE VACCINES, 2013-2018
Figure 23 : GLOBAL MARKET FOR ROTAVIRUS VACCINES, 2012-2018

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Diabetes Statistics in the UK

  • November 2016
    9 pages
  • Therapy  

    Statins  

    Diabetes  

  • United Kingdom  

View report >

Infectious Disease Statistics

  • November 2016
    12 pages
  • Infectious Dise...  

    Therapy  

  • Niger  

    Kenya  

    Africa  

View report >

Influenza Statistics in the US

  • November 2016
    6 pages
  • Infectious Dise...  

    Influenza  

  • United States  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.